Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Novel Measures of Cognition and Function for Alzheimer's Disease Prevention Trials

NCT03900273 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03900273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03900273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Novel Measures of Cognition and Function for Alzheimer's Disease Prevention Trials
Lead sponsor
New York State Psychiatric Institute
Phase
Not applicable
Overall status
Suspended
Start date
February 25, 2019
Completion date
August 31, 2026
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants